Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +1.23% | +15.80% | +13.44% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.44% | 87.85M | |
+9.34% | 105B | |
-1.04% | 104B | |
+4.51% | 22.94B | |
-11.62% | 22.34B | |
-6.36% | 19.25B | |
-39.98% | 17.08B | |
-8.74% | 16.96B | |
+8.14% | 14.16B | |
+38.48% | 12.63B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q4 Revenue $73.5M, vs. Street Est of $18.6M